SCHEMBL9040439

SCHEMBL9040439

O=C(O)n1ccc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.51
SCN4A P35499 4/20 0.48
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRE P78334 1/20 0.43
GABRA6 Q16445 1/20 0.43
GABRG1 Q8N1C3 1/20 0.43
GABRG3 Q99928 1/20 0.43
GABRQ Q9UN88 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
RPA1 P27694 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22341331 0.83 SCN4A (0.55) SCN9ASCN4AGABRPGABRDGABRA1
SCHEMBL21590334 0.82 SCN4A (0.48) SCN9ASCN4ASMN1; SMN2KDM4ENPC1
SCHEMBL22341260 0.82 SCN4A (0.61) SCN9ASCN4ASMN1; SMN2RPA1MAPT
SCHEMBL16974003 0.82 SMN1; SMN2 (0.50) SCN9ASCN4ASMN1; SMN2MAPTALPL
SCHEMBL18128031 0.82 KEAP1 (0.55) SCN9ASCN4ASMN1; SMN2RPA1MAPT
SCHEMBL7055588 0.78 SCN4A (0.55) SCN4AGABRPGABRDGABRA1GABRB1
SCHEMBL12988415 0.78 SCN9A (0.48) SCN9ASCN4AGABRPGABRDGABRA1
SCHEMBL25411454 0.77 SCN4A (0.50) SCN9ASCN4ASMN1; SMN2MAPTCA12
SCHEMBL18127956 0.77 SCN4A (0.65) SCN9ASCN4AGABRA1GABRB2SMN1; SMN2
SCHEMBL4760337 0.77 POLB (0.47) GABRA5MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 EP claimed
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP disclosed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed